Summary
The Sensex rose 564.03 points to close at 74,858.99 while the Nifty 50 gained 67.90 points to end at 23,414.30 on Monday, 21 September 2026, as risk appetite improved after oil prices declined and global bond yields softened.
Nifty FMCG, Pharma, Healthcare, Realty and Consumer Durables outperformed while Metal and PSU Bank lagged, with Eternal, HCL Technologies and SBI Life the top Nifty gainers.
Pharma stocks rose up to 6% in a third straight day of defensive buying led by Mankind Pharma and Wockhardt, while Saatvik Green Energy climbed 5% after Motilal Oswal flagged up to 23% upside on its ₹9,700 crore order book.
Fresh ICRA Analytics data showed equity’s share in women-led mutual fund portfolios has jumped from 40% to 65% in five years, and crude extended its slide with WTI falling below $100 to $98.60.
The Sensex rose 564.03 points, or 0.76%, to close at 74,858.99, while the Nifty 50 ended 67.90 points, or 0.29%, higher at 23,414.30.
The broader market took a breather after Friday’s surge. The Nifty MidCap slipped 0.29% and the Nifty SmallCap eased 0.07%, a mild pause rather than a reversal after their strong recent run.
Impact on the stock market
Sectoral gainers: Nifty FMCG, Nifty Pharma, Nifty Healthcare, Nifty Realty and Nifty Consumer Durables outperformed, with the pharma and healthcare indices rising over 1% each as the top sectoral gainers.
Sectoral losers: Nifty Metal and Nifty PSU Bank underperformed, with metals cooling as global commodity sentiment softened alongside bond yields.
| Sector/Index | Performance |
| IT & BPM sector | -0.08% |
| Healthcare sector | 1.10% |
| Oil & Gas sector | 0.53% |
| Real estate sector | 1.14% |
| PSU Bank in India | -0.06% |
Top gainers today
| Company | Share Price (in ₹) | Change % |
| Eternal | 335.90 | 2.77 |
| HCL Tech | 1,281.00 | 2.54 |
| ITC | 267.00 | 1.79 |
| Sun Pharma | 1,868.90 | 1.72 |
| Reliance | 1,247.40 | 1.71 |
Top losers today
| Company | Share Price (in ₹) | Change % |
| Bharti Airtel | 1,830.20 | -3.33 |
| Adani Ports | 1,787.10 | -2.02 |
| Bajaj Finance | 1,021.30 | -1.83 |
| Power Grid Corp | 266.10 | -1.55 |
| Adani Enterprise | 2,975.00 | -1.49 |
Market aftermath: Impact on stocks
Pharma Stocks: Up to 6% Gains as the Defensive Rally Enters Its Third Day
Pharmaceutical stocks extended their winning run to a third straight session, with Mankind Pharma, Wockhardt and Laurus Labs gaining between 3% and 6%, while Nifty 50 heavyweights Sun Pharmaceutical Industries and Dr Reddy’s Laboratories rose around 2% each. The Nifty Pharma and Nifty Healthcare indices climbed over 1% apiece to top the sectoral leaderboard, taking the pharma index’s three-session gain to more than 3%. More than half the constituents of the Nifty Pharma index traded higher.
The rally has two engines, with defensive buying during a volatile phase for equities meeting a genuine structural story of upcoming launches and new drug approvals. A recent example is Dr Reddy’s agreement with Takeda Biopharmaceuticals India to exclusively distribute Qdenga, India’s first dengue vaccine, in the private market. Brokerages remain constructive too, with Geojit Investments retaining its Buy rating on Sun Pharma with a target of ₹2,070, implying upside of up to 10.5%.
Saatvik Green Energy: A 5% Rise on a ₹9,700 Crore Order Book
Solar module maker Saatvik Green Energy climbed 5% to ₹432.6 after Motilal Oswal reiterated its Buy rating with a target price of ₹508, implying upside of up to 23%. The trigger for the note was a 600 MWp module order worth ₹1,040 crore from state-run SECI under the domestic content requirement route, which mandates modules built with Indian-made cells for government-backed projects, with deliveries scheduled for December 2027. The brokerage said the pricing is below prevailing utility-scale rates but helps the company build base utilisation and a steady pipeline from large utilities.
The bigger picture is order visibility, with the order book growing from ₹8,200 crore in mid-August to ₹9,700 crore now, covering 100% of the brokerage’s revenue estimate for this financial year and 60% for the next. Motilal Oswal expects module sales of 3.6 GW this year rising to 4.7 GW next year, helped by a new 2.4 GW cell manufacturing line starting in the December quarter, and projects revenue and operating profit growth of 36% and 50% a year through FY28. With India’s installed solar capacity reaching 168 GW by August 2026, the company sits in the middle of a sector still expanding rapidly.
The Investor Shift: Equity Now 65% of Women-Led Mutual Fund Portfolios
Away from the ticker, ICRA Analytics released data that says a lot about who is driving India’s equity culture, with the share of equity funds in women-led mutual fund assets rising from 40% in March 2020 to 65% in March 2025. Investors in smaller cities are showing the same preference, with equity schemes accounting for 65.9% of mutual fund assets in beyond-top-30 locations as of July 2026, against 39.8% in the top 30 cities. Across the industry, equity’s share of assets has risen from 27% to 45% over five years.
The scale of the shift is striking, with equity mutual fund assets growing from ₹12.3 lakh crore in August 2021 to ₹39.2 lakh crore in August 2026 and folios rising from 7.3 crore to 18.9 crore, with folio counts continuing to grow even during market corrections. Net equity inflows stood at ₹29,329 crore in August 2026, and the equity fund category has delivered an average five-year return of 12.84% a year against 8.32% for the Nifty 50 total return index. For a market navigating oil shocks and boardroom battles, this steadily broadening base of systematic investors is the quiet stabiliser underneath.
Crude Oil: WTI Falls Below $100 as the Slide Continues
The oil market extended its retreat on Monday. Crude oil futures for October delivery on the MCX fell ₹138, or 1.5%, to ₹9,085 per barrel, while globally WTI declined 1.69% to $98.60, dropping below the $100 mark, and Brent eased 1.59% to $102.22 in New York. Analysts said participants offloaded holdings amid weak demand in the spot market and soft global trends.
The decline matters well beyond the commodity desk, since cheaper crude was the very trigger for Monday’s improved risk appetite in equities, alongside softening global bond yields. Brent has now come down from above $107 last week as Saudi repair efforts and workaround cargoes calm supply nerves. Sustained follow-through, especially after Tuesday’s meeting between the US and Gulf leaders, would remove the single biggest pressure point on Indian inflation and rates.
Conclusion
Monday’s 564-point Sensex gain was a straightforward relief rally, with cooling oil and softer bond yields giving investors room to buy, and the defensive pharma trade running alongside growth stories like Saatvik’s expanding order book. The ICRA data adds useful perspective, showing that whatever the daily headlines, equity participation keeps broadening across women investors and smaller cities, which deepens the market’s domestic foundation. The caution notes are the midcap and smallcap pause and the PSU bank weakness, a reminder that the rally remains selective. With WTI below $100 and the Gulf leaders’ meeting due on Tuesday, the oil story is at a potential turning point, and this week will show whether the market’s improving mood has real staying power.
